Pozen, Inc. (POZN) Takes Another Step To No Longer Being A Drug Developer; Shrinks Workforce
San Diego Startup, Hera Therapeutics, Unveils Drug For Viral Infections Tied To Cervical Cancer
Unnamed Drug Firm May Invest Up To €1 Billion In Ireland, Hundreds Of New Jobs Expected
Phosphagenics Limited (POH.AX)'s Ex-Chief Guilty Of Theft
Allergan Inc. (AGN) Loses Battle To Make Shareholder Vote Moot On Valeant Pharmaceuticals International (VRX) Bid
NeuroDerm Ltd. Banks $16 Million
FDA Approves Use Of Bristol-Myers Squibb Company (BMY), Pfizer Inc. (PFE)'s Eliquis To Treat Leg, Lung Clots
Look Out Auxilium Pharmaceuticals (AUXL), BioSpecifics Technologies Corporation (BSTC) Also Touts Positive Data From Phase 2a Study Of CCH For Cellulite
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) Gains $20 Million Through Deal With Janssen Research & Development
Sprout Pharmaceuticals Eyes $15 Million From Private Investors To Develop Female Viagra
Update: OncoGenex Pharmaceuticals Inc. (OGXI) Phase 3 ENSPIRIT Trial Continuing As Planned
Ghent University, Flemish Institute For Biotechnology To Develop New Site For R&D Companies, 2,000 New Jobs To Be Created
Pfizer Inc. (PFE) Eyes Possible Actavis (ACT) Bid Whilst Weighing Next Steps Over AstraZeneca PLC (AZN)
Galena Biopharma  (GALE) CEO Allegedly Fired Following Stock-Promotions Scandal, New CEO Named
Auxilium Pharmaceuticals (AUXL) Drug Found Effective Against Cellulite In Phase 2 Study
Illumina, Inc. (ILMN) Partners With AstraZeneca PLC (AZN), Johnson & Johnson (JNJ) To Create New Genetic Tests For Cancer
Mylan Inc. (MYL) Makes Second Round Of Bidding For GlaxoSmithKline (GSK) Drug Portfolio
Baxter International, Inc. (BAX) To Invest $300 Million For Facility Expansion, Will Hire 200 New Workers
See All News >
Pfizer Inc. (PFE) Eyes Possible Actavis (ACT) Bid Whilst Weighing Next Steps Over AstraZeneca PLC (AZN)
Best Biotech Employers In America
Galena Biopharma  (GALE) CEO Allegedly Fired Following Stock-Promotions Scandal, New CEO Named
Auxilium Pharmaceuticals (AUXL) Drug Found Effective Against Cellulite In Phase 2 Study
Illumina, Inc. (ILMN) Partners With AstraZeneca PLC (AZN), Johnson & Johnson (JNJ) To Create New Genetic Tests For Cancer
Mylan Inc. (MYL) Makes Second Round Of Bidding For GlaxoSmithKline (GSK) Drug Portfolio
Baxter International, Inc. (BAX) To Invest $300 Million For Facility Expansion, Will Hire 200 New Workers
Ebola-Like Virus Beaten By Tekmira Pharmaceuticals Corporation (TKMR) Drug In Study
FDA Finds Falsified Data, Serious Mold, And Decaying Frogs At Amanta (Formerly Known As Marck Biosciences)
Amicus Therapeutics, Inc. (FOLD) Rockets On Positive Phase 3 Study Data For Rare Disease Drug
Eli Lilly and Company (LLY)'s Psoriasis Drug Ixekizumab Succeeds In Late-Stage Studies
Popular Antibiotic Linked To Increased Heart Risk, British Medical Journal Reveals
GlaxoSmithKline (GSK)'s Asthma Treatment Wins FDA Approval
Dr. Reddy's Laboratories, Inc. (RDY)'s Breached Packaging Rules: U.S. Regulator
Why Older People Have Trouble Sleeping, Beth Israel Medical Center And University of Toronto Reveal
Young Blood To Be Used In Ultimate Rejuvenation Trial, Stanford University Reveals
More Exits From Ranbaxy Laboratories (RANBAXY.BO)' Top Management Team
How Illumina, Inc. (ILMN) Is Creating Medicine's Genetic Revolution
See All News >
//-->